|
Jean-Louis Anspach joined Unimed Pharmaceuticals, Inc. as president and Chief Executive Officer in June 2001. Prior to joining Unimed, Anspach was Director of Business Development for Solvay Pharmaceuticals, Inc. Previously, Anspach served as President and CEO of Solvay Fluorides, Inc. and Solkatronic Chemicals, Inc., both in the United States. Anspach also held positions as Head of External Communications and Investor Relations for Solvay, S.A. and as Financial Analyst in the Corporate Finance Department in Brussels, Belgium. Anspach earned his MBA from the University of Wisconsin in Madison, Wis. and an Ingenieur Commercial degree from the Université Libre de Bruxelles, the Solvay Business School in Brussels, Belgium. |